Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

2,235 evidence items · page 62 / 90

38.6 %During periods of self-reported HIV risk, the difference in time covered by PrEP/PEP between the dynamic choice prevention and standard-of-care arms was 38.6%.

KenyaVIH/sidapublished 2024AIDS (London, England)PubMeddocument of 18 observations

0.91 hazard_ratioThere was no difference in the hazard of healing between 108 HIV-positive and 108 age-matched HIV-negative men (HR 0.91, 95% CI 0.70–1.20).

KenyaVIH/sidapublished 2013PloS oneeurope_pmcdocument of 6 observations

3.66 USD_per_client_monthThe estimated economic cost per client-month on PEP was $3.66 USD for subsidized delivery.

KenyaVIH/sidapublished 2025BMC health services researchPubMeddocument of 13 observations

404 individualsThis study followed 404 HIV-positive women who contributed 2753 quarterly examination visits.

KenyaVIH/sidapublished 2017Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 5 observations

3.8 %Pre-acquisition CD8(+) T-cell responses were associated with enhanced post-acquisition HIV-specific CD8(+) T-cell proliferation of 3.8% compared to 1.0% (P=0.03).

KenyaVIH/sidapublished 2010AIDS (London, England)europe_pmcdocument of 2 observationsDOI 10.1097/qad.0b013e3283391d40

13.7 %Overall provider-initiated testing and counselling (PITC) coverage was 13.7% among adult outpatients aged 18–39 years at six health facilities in coastal Kenya.

KenyaVIH/sidapublished 2021PloS onePubMeddocument of 7 observations

34.54 USDThe average unit cost per male sex partner (MSP) traced was $34.54.

KenyaVIH/sidapublished 2022BMC health services researchPubMeddocument of 13 observations

1.8 per_100_person-yearsThe incidence rate difference was 1.8 per 100 person-years between the standard-of-care and intervention groups.

KenyaVIH/sidapublished 2024The lancet. HIVPubMeddocument of 9 observations

9.9 %Cumulative lost to follow-up incidence among children and adolescents initiating antiretroviral therapy in central Kenya was 9.9% at 12 months.

KenyaVIH/sidapublished 2022AIDS research and human retrovirusesPubMeddocument of 18 observations

94 %HIV self-testing acceptance was 94% in bars/clubs among adolescents and young adults in an urban settlement in Kenya.

KenyaVIH/sidapublished 2022AIDS and behaviorPubMeddocument of 3 observations

Among adolescent girls in Kenya, HIV testing increased between 2016/2017 and 2018.

KenyaVIH/sidaobserved 2016/2017, 2018published 2022BMJ openPubMeddocument of 18 observations

994 womenOverall, 994 HIV-negative pregnant Kenyan women enrolled in the study.

KenyaVIH/sidaobserved November 2017 to June 2019published 2024PloS onePubMeddocument of 5 observations

9 %Among females ineligible for assisted partner services (aPS), 9% had a previous HIV diagnosis.

KenyaVIH/sidaobserved May 2018 to August 2019published 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 12 observations

96 %HIV and malaria had the highest response rate (greater than 96%) and the broadest coverage in diagnostic capacity across facilities (greater than 76%).

Kenyapaludisme · VIH/sidaobserved 2018published 2023BMC health services researchPubMeddocument of 7 observations

14.34 %HIV prevalence among long-distance truckers in the region is 14.34%.

KenyaVIH/sidapublished 2025Journal of the International Association of Providers of AIDS CarePubMed

43.9 %Among 911 women in the PrEP Implementation of Mothers in Antenatal Care trial in Kenya, 43.9% perceived themselves to be at high risk of HIV.

KenyaVIH/sidapublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 11 observations

92.5 %Among 4708 PLHIV initiated on IPT in Kenya between July 2015 and June 2018, 4356 (92.5%) had ever been screened for tuberculosis at every clinic visit.

Kenyatuberculose · VIH/sidaobserved July 2015 to June 2018published 2020PloS onePubMeddocument of 8 observations

50 %In the absence of timely HIV testing and Antiretroviral Therapy (ART) initiation, more than half of infants living with HIV die before 2 years.

KenyaVIH/sidapublished 2020African Journal of Health SciencesOpenAlexdocument of 9 observations

6.9 %Overall pre-treatment HIV drug resistance increased from 6.9% before 2005 to 24.2% during 2016–2020 in Kenya.

KenyaVIH/sidaobserved before 2005published 2024The Journal of antimicrobial chemotherapyPubMeddocument of 7 observations

3.1 per_100_person_yearsHIV incidence was 3.10 per 100 person-years in a higher-risk group of female sex workers in Mombasa, Kenya.

KenyaVIH/sidaobserved 2010 to 2017published 2021AIDS and behavioreurope_pmcdocument of 4 observations

14 %In Kibera, 14% of people living with HIV reported missing medications at the onset of the COVID-19 pandemic.

KenyaVIH/sidapublished 2021International journal of environmental research and public healthPubMeddocument of 7 observations

16.9 %In the APS+HIVST arm, 16.9% (357/2111) of partners tested were newly diagnosed with HIV.

KenyaVIH/sidaobserved 2021published 2024Journal of the International AIDS SocietyPubMeddocument of 15 observations

51 %Among the 705 HIV patients, 51% were married.

KenyaVIH/sidapublished 2023BioMed research internationalPubMeddocument of 6 observations

49 %Among HIV-positive children in Kenya, 49% were virally suppressed in 2018.

KenyaVIH/sidaobserved 2018published 2022PloS onePubMeddocument of 10 observations

0.05 odds_ratioIntervention arm caregivers had less food insecurity than those in the control arm, with an odds ratio of 0.05 (95% CI 0.0047 to 0.54; p=0.014).

KenyaVIH/sidapublished 2026BMJ global healthPubMeddocument of 9 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.